Citadel Advisors - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is and the CUSIP is 743187956. A total of 2 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$59,000
-48.2%
13,900
-46.7%
0.00%
Q1 2016$114,000
-7.3%
26,100
+29.9%
0.00%
Q4 2015$123,000
+68.5%
20,100
+57.0%
0.00%
Q3 2015$73,000
-70.3%
12,800
-61.2%
0.00%
Q2 2015$246,000
+141.2%
33,000
+94.1%
0.00%
Q1 2015$102,000
+108.2%
17,000
+161.5%
0.00%
Q4 2014$49,000
+2350.0%
6,500
+2066.7%
0.00%
Q3 2014$2,000
-95.2%
300
-96.9%
0.00%
Q2 2014$42,000
-44.0%
9,700
-47.3%
0.00%
Q1 2014$75,000
-80.7%
18,400
-74.8%
0.00%
-100.0%
Q4 2013$389,000
+322.8%
73,000
+298.9%
0.00%
Q3 2013$92,000
+84.0%
18,300
+63.4%
0.00%
Q2 2013$50,00011,2000.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q3 2016
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 82,300$521,0000.01%
SIMPLEX TRADING, LLC 39$1,0000.00%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders